Company profile: Alpha-Tec Systems
1.1 - Company Overview
Company description
- Provider of accurate specimen collection, transportation, processing, and quality control solutions for clinical labs, including AFB processing systems (NAC-PAC EA3, UNITARY, RED), fertility and immune testing products (QC-Beads, CitricScreen, FructoScreen, LeucoScreen, ImmunoSpheres, MarScreen), Microbix REDx and PROCEEDx controls, and the OxA oxalic acid decontamination kit for Pseudomonas spp.
Products and services
- NAC-PAC EA3: Standardized AFB specimen processing system with NALC tablets or powder, engineered to improve mycobacteria recovery rates in clinical laboratories
- NAC-PAC UNITARY: Individualized AFB processing system using pre-aliquoted reagents for each patient sample to eliminate cross-contamination, created for precise, sample-specific specimen handling
- Microbix Controls: Clinical-grade quality control products for laboratory testing performance, featuring REDx and PROCEEDx controls for various infectious disease pathogens to support testing performance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alpha-Tec Systems
Clever Culture Systems
HQ: Switzerland
Website
- Description: Provider of intelligent image analysis solutions using artificial intelligence, including APAS Independence for automated microbial environmental monitoring with digital records, audit trails, standardized workflows and reduced human error, and MRSA and VRE Analysis Modules that automate detection on chromogenic media for efficient infection control by reporting negatives and triaging positives for review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clever Culture Systems company profile →
Eurocine Vaccines
HQ: United States
Website
- Description: Provider of nasal flu vaccines for children and the elderly, managing preclinical and clinical development, scalability into manufacturing, business development, and funding. Offers Endocine, a nasal vaccine adjuvant used in clinical trials showing safety and tolerability in over 400 human subjects; an HSV-2 therapeutic vaccine candidate; and vaccine development services from conceptualization to commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurocine Vaccines company profile →
Leyden Labs
HQ: The Netherlands
Website
- Description: Provider of a mucosal immunity platform targeting commonalities of viral families to protect against known and future respiratory viruses, offering intranasal antibody sprays for immediate antiviral protection, including PanFlu nasal spray (CR9114 antibody) for broad influenza protection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Leyden Labs company profile →
Stat-Dx
HQ: Spain
Website
- Description: Provider of near-patient testing products for healthcare professionals, primarily for short turnaround time applications and critical care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stat-Dx company profile →
Calixa Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical drug development focused on a novel cephalosporin to address multi-drug resistant organisms, targeting infections caused by resistant gram-negative bacteria, especially Pseudomonas aeruginosa.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calixa Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alpha-Tec Systems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alpha-Tec Systems
2.2 - Growth funds investing in similar companies to Alpha-Tec Systems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alpha-Tec Systems
4.2 - Public trading comparable groups for Alpha-Tec Systems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →